AGM
SANA icon

Alpine Global Management’s Sana Biotechnology SANA Stock Holding History

Alpine Global Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-34,181
Closed -$187K – 422
2024
Q2 		$187K Buy
+34,181
New +$272K 0.03% 316

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return

Alpine Global Management's SANA Position: Q3 2024 in Review

Alpine Global Management sold out of Sana Biotechnology (SANA) in Q3 2024, closing a stake of 34,181 shares — an estimated $187K sold.

Alpine Global Management first reported a position in SANA in Q2 2024 and held it in 1 quarter. The position peaked at $187K in Q2 2024. 155 funds tracked by Wall St. Rank hold SANA as of Q3 2024.

  • Alpine Global Management reported no remaining Sana Biotechnology position as of Q3 2024 after selling out during the quarter.
  • Alpine Global Management sold 34,181 Sana Biotechnology shares in Q3 2024, an estimated $187K.
  • Alpine Global Management first reported a position in Sana Biotechnology in Q2 2024 and held it in 1 quarter.
  • Alpine Global Management's Sana Biotechnology position peaked at $187K in Q2 2024.
  • 155 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2024.

Based on Alpine Global Management's 13F filing for Q3 2024, filed 14 Nov 2024.